Posted inBlog
Dr. Lal PathLabs Q3 results: Profit rises 54% to Rs 81.3 cr, revenue up 10%
Dr. Lal PathLabs's shares climbed 14% in 2023, sandwiched between Metropolis' 26% rise and Thyrocare's 4% bump
Dr. Lal PathLabs, India's biggest diagnostics firm by revenue, posted a higher profit…
